A detailed history of Logos Global Management LP transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Logos Global Management LP holds 2,000,000 shares of LIFE stock, worth $3.72 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
2,000,000
Previous 3,000,000 33.33%
Holding current value
$3.72 Million
Previous $4.68 Million 20.51%
% of portfolio
0.49%
Previous 0.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.24 $1.51 Million - $2.24 Million
-1,000,000 Reduced 33.33%
2,000,000 $3.72 Million
Q2 2024

Aug 14, 2024

SELL
$0.0 - $2.07 $0 - $206,999
-100,000 Reduced 3.23%
3,000,000 $4.68 Million
Q1 2024

May 15, 2024

SELL
$1.42 - $2.02 $3.91 Million - $5.56 Million
-2,750,000 Reduced 47.01%
3,100,000 $6.05 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $1.51 $6.49 Million - $8.83 Million
5,850,000 New
5,850,000 $8.25 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.